Relationship between selected overdrive parameters and the therapeutic outcome and tolerance of atrial overdrive pacing

被引:4
作者
Attuel, P
Danilovic, D
Konz, KH
Brachmann, J
EL Allaf, D
Löscher, S
Gomes, C
Scheibner, T
Schibgilla, V
Szendey, I
Hartmann, A
机构
[1] Ctr Medicochirurg Parly 2, F-78150 Le Chesnay, France
[2] Biotron GMBH, Clin Dept, Erlangen, Germany
[3] St Franziskus Hosp, Maria Hilf Clin, Med Clin 2, Monchengladbach, Germany
[4] Coburg Clin gGMBH, Med Clin 2, Coburg, Germany
[5] Hutois Hosp Ctr, Huy, Belgium
[6] St Georg Hosp, Dept Internal Med 1, Leipzig, Germany
[7] Heart Inst Incore, Taguatinga, Brazil
[8] Internist Cardiol Practice, Lobau, Germany
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2003年 / 26卷 / 01期
关键词
D O I
10.1046/j.1460-9592.2003.00028.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a paucity of information on the influence of selected overdrive parameters on the clinical efficacy and tolerance of atrial overdrive algorithms to suppress atrial tachyarrhythmias. Data from a completed clinical trial investigating a new DDD+ overdrive algorithm implemented in a permanent pacemaker were analyzed. One-hundred patients with standard pacing indications and atrial tachyarrhythmias were enrolled and followed for 6 months in DDD and 6 months in DDD+ mode in a randomized, crossover fashion. The overdrive step size was programmed at the discretion of the investigators between 4 and 12 beats/min, overdrive plateau length between 10 and 32 beats, and maximum overdrive rate between 100 and 160 beats/min. The effects of DDD+ versus DDD mode on burden and incidence of atrial tachyarrhythmias stored in the mode switch memory were examined as a function of the programmed overdrive parameters. An overdrive step size between 7 and 12 beats/min, and higher a maximum overdrive rote between 121 and 160 beats/min were slightly more effective than lower programmed values, though > 500 randomized, crossover observations would have been necessary to verify statistical significance. Overdrive pacing related symptoms mandated early manual deactivation of overdrive pacing in 4.7% of 85 evaluated patients. Overdrive was disabled without testing tolerability of less aggressive overdrive values. There was no link between patient symptoms and programmed overdrive step size or overdrive plateau length values.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 10 条
[1]  
ATTUEL P, 2000, HERZSCHRITTMACHER, V20, P104
[2]  
BEREMANN MJS, 2000, HERZSCHRITTMACHER, V20, P47
[3]  
CAMM AJ, 2002, PACE, V25, P554
[4]   Conflicting issues in permanent right atrial lead positioning [J].
Israel, CW .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (11) :1581-1584
[5]  
ISRAEL CW, 2000, HERZSCHRITTMACHER, V20, P8
[6]  
ISRAEL CW, 1999, PROG BIOMED RES, V4, P117
[7]   Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation [J].
Lam, CTF ;
Lau, CP ;
Leung, SK ;
Tse, HF ;
Lee, KLF ;
Tang, MO ;
Tsang, V .
EUROPACE, 2000, 2 (04) :286-291
[8]   A NEW PACING ALGORITHM FOR OVERDRIVE SUPPRESSION OF ATRIAL-FIBRILLATION [J].
MURGATROYD, FD ;
NITZSCHE, R ;
SLADE, AKB ;
LIMOUSIN, M ;
ROSSET, N ;
CAMM, AJ ;
RITTER, P .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1994, 17 (11) :1966-1973
[9]   Atrial arrhythmia suppression by atrial overdrive pacing: pacemaker Holter assessment [J].
Ward, KJ ;
Willett, JE ;
Bucknall, C ;
Gill, JS ;
Kamalvand, K .
EUROPACE, 2001, 3 (02) :108-114
[10]  
WIBERG S, 2001, PACING CLIN ELECTROP, V24, P554